Healthcare · Pharmaceutical expenditure
Sweden's pharmaceutical expenditure stands at 1.18 % GDP of GDP in 2026 — a moderate figure reflecting a balanced drug policy. The Nordic healthcare model emphasises prevention and rational prescribing, keeping costs in check without compromising quality. Meanwhile, the country fosters a strong biopharma sector: clusters around Uppsala and Lund are among Europe's leading hubs for innovative drug development. Sweden ranks 101 out of 197 in this indicator.
Data for 2026 · unit: % GDP
Position
#101 / 197
Sweden world ranking
Country position on the scale from last to first place for this indicator.
SE
#101
#197#1
Trend
Change over time
Change in indicator over the available period.
1.10
1990
1.30
2000
1.20
2010
1.15
2020
1.18
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Sweden stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Sweden — how much?
Based on 2026 data — 1.18 % GDP. This is rank #101 out of 197 countries.
What is Sweden's rank by Pharmaceutical expenditure?
Sweden ranks #101 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Sweden?
Over the available period the indicator changed from 1.10 to 1.18 % GDP.